JAK2 V617F-mutated polycythemia vera developing in a patient with a 20-year-long chronic myeloid leukemia at the time of first molecular response

Luca Tosoni¹, Dora Fabbro², Umberto Pizzano¹, Rikard Mullai¹, Gianluca Morelli¹, Alessandra Franzoni², Giuseppe Damante^{2

3}, Eleonora Toffoletti^{1

3}, Daniela Damiani^{1

3}, Renato Fanin^{1

3}, Mario Tiribelli^{4

5}

Affiliations

¹ Division of Hematology and Bone Marrow Transplantation, Azienda Sanitaria Universitaria Friuli Centrale, P.Le S. M. Misericordia 15, 33100, Udine, Italy.
² Institute of Medical Genetics, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
³ Department of Medicine, University of Udine, Udine, Italy.
⁴ Division of Hematology and Bone Marrow Transplantation, Azienda Sanitaria Universitaria Friuli Centrale, P.Le S. M. Misericordia 15, 33100, Udine, Italy. mario.tiribelli@uniud.it.
⁵ Department of Medicine, University of Udine, Udine, Italy. mario.tiribelli@uniud.it.

Case Reports

Luca Tosoni et al. Ann Hematol. 2023 May.

. 2023 May;102(5):1279-1280.

doi: 10.1007/s00277-023-05187-5. Epub 2023 Mar 22.

¹ Division of Hematology and Bone Marrow Transplantation, Azienda Sanitaria Universitaria Friuli Centrale, P.Le S. M. Misericordia 15, 33100, Udine, Italy.
² Institute of Medical Genetics, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
³ Department of Medicine, University of Udine, Udine, Italy.
⁴ Division of Hematology and Bone Marrow Transplantation, Azienda Sanitaria Universitaria Friuli Centrale, P.Le S. M. Misericordia 15, 33100, Udine, Italy. mario.tiribelli@uniud.it.
⁵ Department of Medicine, University of Udine, Udine, Italy. mario.tiribelli@uniud.it.

No abstract available

Comment in

Comment on: JAK2 V617F-mutated polycythemia vera developing in a patient with a 20-year-long chronic myeloid leukemia at the time of first molecular response.
Tsilimidos G, Blum S. Tsilimidos G, et al. Ann Hematol. 2023 Sep;102(9):2619-2620. doi: 10.1007/s00277-023-05297-0. Epub 2023 May 31. Ann Hematol. 2023. PMID: 37256305 No abstract available.

1. Nangalia J, Green AR (2017) Myeloproliferative neoplasms: from origins to outcomes. Blood 130:2475–2483 - DOI - PubMed
1. Krämer A, Reiter A, Kruth J, Erben P, Hochhaus A, Müller M, Cross NCP, Jones AV, Ho AD, Hensel M (2007) JAK2-V617F mutation in a patient with Philadelphia-chromosome-positive chronic myeloid leukaemia. Lancet Oncol 8:658–660 - DOI - PubMed
1. Kim Y-K, Shin M-G, Kim H-R, Yang D-H, Cho S-H, Lee J-J, Chung I-J, Ryang D-W, Kim H-J (2008) Simultaneous occurrence of the JAK2V617F mutation and BCR-ABL gene rearrangement in patients with chronic myeloproliferative disorders. Leuk Res 32:903–1003 - DOI
1. Pardini S, Fozza C, Contini S, Rimini E, Ottaviani E, Amabile M, Rosti G, Longinotti M (2008) A case of coexistence between JAK2V617F and BCR/ABL. Eur J Haematol 81:75–76 - DOI - PubMed
1. Yamada O, Mahfoudhi E, Plo I, Ozaki K, Nakatake M, Akiyama M, Yamada H, Kawauchi K, Vainchenker W (2014) Emergence of a BCR-ABL translocation in a patient with the JAK2V617F mutation: evidence for secondary acquisition of BCR-ABL in the JAK2V617F clone. J Clin Oncol 32:e76–e79 - DOI - PubMed